Annals of African medicine · 2009
The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tukur Jamilu
Аннотация
BACKGROUND: Pre-eclampsia and eclampsia are important causes of maternal and perinatal morbidity and mortality in the developing countries. There is need to provide the most effective management to pre-eclamptic and eclamptic patients. There is now evidence that magnesium sulphate is the most effective anticonvulsant.
METHOD: In this article , a literature review was made on the contribution of pre-eclampsia and eclampsia to maternal mortality and how it can be curtailed by the use of magnesium sulphate.
RESULTS: The drug is administered by the Pritchard or Zuspan regimen, although modifications in the two protocols have been reported.
CONCLUSION: A Nigerian national protocol has been developed on its use. There is need for further training of health workers on how to use this important drug.
METHOD: In this article , a literature review was made on the contribution of pre-eclampsia and eclampsia to maternal mortality and how it can be curtailed by the use of magnesium sulphate.
RESULTS: The drug is administered by the Pritchard or Zuspan regimen, although modifications in the two protocols have been reported.
CONCLUSION: A Nigerian national protocol has been developed on its use. There is need for further training of health workers on how to use this important drug.